Enterprise Solutions Webinars
-
Inline Buffer Formulation Systems
7/6/2026
Eliminate large storage tanks and optimize cleanroom space with automated inline buffer formulation. See how on-demand fluid handling provides precise, real-time pH and conductivity control.
-
Trusted Performance With A Plus: Seamless Transfer From R&D To Commercial
7/5/2026
Bridge the gap between early R&D and commercial biomanufacturing. Learn how scalable control architectures, automated gassing strategies, and digital validation protocols streamline tech transfers.
-
Streamline Fluid Disconnections And Reduce Tear-Down Complexity
7/5/2026
Accelerate process turnover and fortify fluid line sterility without complex tools. Gain insight into how modern, metal-free connector geometries mitigate spillage and preserve cell viability.
-
Productivity Gains Upstream Apply Pressure Downstream
7/1/2026
In this segment from the Bioprocess Online Live event, “The Levers And Tradeoffs That Drive Process Productivity,” panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), reflect on the progress that’s been made in terms of productivity gains and the “ceiling” that mAbs face, and how these upstream gains stress downstream operations. They also discuss how molecular complexity relates to challenges in purification.
-
Continuous Manufacturing As A Powerful Productivity Lever
7/1/2026
In this segment from the Bioprocess Online Live event, “The Levers And Tradeoffs That Drive Process Productivity,” panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), discuss the potential of perfusion and continuous manufacturing to improve productivity through smaller facility footprints and greater output over time. They also examine the challenges associated with these approaches, including cell-line stability, process monitoring, and the cost of operational mistakes.
-
Understanding Fixed Variables And Working Within Their Constraints
7/1/2026
Some things are intrinsic, unchanging realities of a process — molecular complexity, product developability, and facility fit, to name a few. In this segment from the Bioprocess Online Live event, “The Levers And Tradeoffs That Drive Process Productivity,” panelists David Scherr, Ph.D. (AstraZeneca) and Vadim Klyushnichenko, Ph.D. (Calibr-Skaggs), discuss these “non-pullable levers” of process development and advise teams on how to work within their boundaries.
-
Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity
6/30/2026
A bottom-up, data-driven media design approach shows how targeted nutrient optimization overcomes metabolic limits to boost culture performance and titer while maintaining product quality and process consistency.
-
Building Scalable Non-Viral Gene-Edited Cell Therapy Processes
6/24/2026
Rahul Purohit, Ph.D., discusses the challenges and opportunities of scaling non-viral gene-edited cell therapies, with practical guidance for balancing performance, cell quality, and manufacturing readiness.
-
Samsung Biologics Capabilities Update June 2026: ADC
6/19/2026
Explore how our integrated bioconjugation platform and expanded capabilities can help advance the development and scalable manufacturing of next-generation therapeutics.
-
Simtra BioPharma Solutions June 2026 Capabilities Update: ADC
6/19/2026
Coordinate expertise across development, manufacturing, and testing to streamline ADC workflows, cut handoffs, and accelerate timelines — moving teams from early development to commercialization.